Loading...
In vivo and in vitro reconstitution of unique key steps in cystobactamid antibiotic biosynthesis.
Groß, Sebastian Schnell, Bastien Haack, Patrick A Auerbach, David Müller, Rolf
Groß, Sebastian
Schnell, Bastien
Haack, Patrick A
Auerbach, David
Müller, Rolf
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2021-03-16
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 1.7 MB
Other Titles
Abstract
Cystobactamids are myxobacteria-derived topoisomerase inhibitors with potent anti-Gram-negative activity. They are formed by a non-ribosomal peptide synthetase (NRPS) and consist of tailored para-aminobenzoic acids, connected by a unique α-methoxy-L-isoasparagine or a β-methoxy-L-asparagine linker moiety. We describe the heterologous expression of the cystobactamid biosynthetic gene cluster (BGC) in Myxococcus xanthus. Targeted gene deletions produce several unnatural cystobactamids. Using in vitro experiments, we reconstitute the key biosynthetic steps of linker formation and shuttling via CysB to the NRPS. The biosynthetic logic involves a previously uncharacterized bifunctional domain found in the stand-alone NRPS module CysH, albicidin biosynthesis and numerous BGCs of unknown natural products. This domain performs either an aminomutase (AM) or an amide dehydratase (DH) type of reaction, depending on the activity of CysJ which hydroxylates CysH-bound L-asparagine. Furthermore, CysQ O-methylates hydroxyl-L-(iso)asparagine only in the presence of the AMDH domain. Taken together, these findings provide direct evidence for unique steps in cystobactamid biosynthesis.
Citation
Nat Commun. 2021 Mar 16;12(1):1696. doi: 10.1038/s41467-021-21848-3.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
EISSN
2041-1723
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution 4.0 International